About
我们是Provectus Therapeutics Limited,一家专注于开发创新癌症治疗方案的生物制药公司。我们的使命是利用新颖的科学方法,推动药物的发现和开发,旨在为癌症患者提供更有效的治疗选择。我们致力于通过我们的技术平台,为全球医疗社区带来突破性的解决方案,改善患者生活。通过合作与创新,我们希望与行业内的其他专业人士一起,共同推动医疗进步。
Technology
Bio-TechMedical Technology
Additional questions
Other Place of Business
Hong Kong
Representatives
Marco SuenFounder & CEO
Provectus Therapeutics Limited
Marketplace (1)
Project
Single Cell Drug Screening AI Platform
Our high-throughput single cell drug testing AI platform accelerate cancer research, drug development, and clinical precision.
- Yes
- None
- Equity
- Bio-Tech
- Technology
- Private Project
- R&D Cooperation
- Open for negotiation
- Professional Services
- Minority Shareholdings
- 2,500,001 to 5,000,000 USD
- 1,000,001 to 2,500,000 USD
- Feasibility Study Completed
- Public–private partnership / Concession
AuthorMarco Suen
Founder & CEO at Provectus Therapeutics Limited
Hong Kong, China (Hong Kong)